Series B funding round for Amal Therapeutics raising $10M in September 2017
Series B funding round for Amal Therapeutics raising $10M in September 2017
| Investor | Firm Type | Partner |
|---|
HelsinnLEAD | Venture Capital | — |
| Private | — | |
BioMedPartnersLEAD | Venture Capital | — |
| Venture Capital | — | |
| Private | — | |
| Corporate Venture Capital | — | |
| Venture Capital | — |
This company has completed 3 funding rounds. Current round is highlighted.
Total Raised
$46M
Top Valuation
-
Amal Therapeutics raised $10M in a Series B round.
The round was announced on 09/01/17.
The round was led by Andreas Wallnoefer, Knut Elbers, Helsinn.